Consistently, germline mutations in SPRTN were identified in patients with a progeroid syndrome characterized by genomic instability and susceptibility toward early‐onset hepatocellular carcinoma (Ruijs‐Aalfs Syndrome/RJALS). The gene discussed is SPRTN; the disease is progeroid syndrome.